Literature DB >> 16864584

Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathway.

E Scott Graham1, Nicola Ball, Emma L Scotter, Pritika Narayan, Mike Dragunow, Michelle Glass.   

Abstract

Neuro2a cells endogenously express cannabinoid type 1 (CB1) receptors. CB1 stimulation with HU210 activated ERK and induced the transcription factor Krox-24. A functional MEK-ERK pathway is an important requirement for CB1-mediated Krox-24 induction as blockade of MEK signaling by UO126 reduces both basal and CB1-mediated activation of Krox-24. CB1 receptor stimulation did not activate either JNK or p38 MAPK pathways or the pro-proliferation phosphatidylinositol 3-kinase (PI3K)-Akt pathway. However, serum removal or blockade of PI3K signaling by LY294002 transiently stimulated basal Krox-24 expression and increased CB1-mediated induction of Krox-24. This was consistent with a transient increase in pMEK, pERK, and pCREB levels following PI3K blockade. These data demonstrate that CB1-mediated activation of the Krox-24 transcription factor is negatively regulated through the PI3K-Akt pathway and reveals several points of signaling cross-talk between these two important kinase pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864584     DOI: 10.1074/jbc.M602516200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Early growth response-1 induction by fibroblast growth factor-1 via increase of mitogen-activated protein kinase and inhibition of protein kinase B in hippocampal neurons.

Authors:  Alexander H Benz; Mehdi Shajari; Natalie Peruzki; Faramarz Dehghani; Erik Maronde
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

3.  Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.

Authors:  Eric A Horne; Jonathan Coy; Katie Swinney; Susan Fung; Allison E T Cherry; William R Marrs; Alipi V Naydenov; Yi Hsing Lin; Xiaocui Sun; C Dirk Keene; Eric Grouzmann; Paul Muchowski; Gillian P Bates; Ken Mackie; Nephi Stella
Journal:  Eur J Neurosci       Date:  2012-11-21       Impact factor: 3.386

4.  Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake.

Authors:  Jonathan H Wardman; Ivone Gomes; Erin N Bobeck; Jennifer A Stockert; Abhijeet Kapoor; Paola Bisignano; Achla Gupta; Mihaly Mezei; Sanjai Kumar; Marta Filizola; Lakshmi A Devi
Journal:  Sci Signal       Date:  2016-05-31       Impact factor: 8.192

5.  Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.

Authors:  E L Scotter; C E Goodfellow; E S Graham; M Dragunow; M Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 6.  Endocannabinoid system in neurodegenerative disorders.

Authors:  Balapal S Basavarajappa; Madhu Shivakumar; Vikram Joshi; Shivakumar Subbanna
Journal:  J Neurochem       Date:  2017-07-05       Impact factor: 5.372

7.  Serpinin: a novel chromogranin A-derived, secreted peptide up-regulates protease nexin-1 expression and granule biogenesis in endocrine cells.

Authors:  Hisatsugu Koshimizu; Niamh X Cawley; Taeyoon Kim; Alfred L Yergey; Y Peng Loh
Journal:  Mol Endocrinol       Date:  2011-03-24

8.  Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development.

Authors:  Nicola J A Scott; Leigh J Ellmers; John G Lainchbury; Nobuyo Maeda; Oliver Smithies; A Mark Richards; Vicky A Cameron
Journal:  Biochim Biophys Acta       Date:  2009-09-24

9.  Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

Authors:  Balapal S Basavarajappa
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

10.  Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.

Authors:  Gemma Nicoll; Scott Davidson; Lynne Shanley; Ben Hing; Marissa Lear; Peter McGuffin; Ruth Ross; Alasdair MacKenzie
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.